In March 2025, the company announced new plans for just a direct-to-consumer providing of its Wegovy weight loss drug. The company recognized a new pharmacy, named NovoCare, which would demand shoppers $499 monthly for entry to the drug, less than 50 percent the cost of the drug by means of othe